Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly vs 3-Weekly Docetaxel in Advanced Breast Cancer
NCT00540800Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2004
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by National Cancer Institute. Started Feb 2004; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00540800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540800.